No Detail Found!

Hypertension and Related Risk Factors among Clients on Combined Antiretroviral Therapy in Offa, Nigeria.

Author(s)
Shakirat I Bello Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmaceutical Sciences, University of Ilorin, Ilorin, Nigeria
Winified A Ojieabu Department of Clinical Pharmacy and Bio-pharmacy, Faculty of Pharmacy, Olabisi Onabanjo University, Shagamu, Nigeria
Abstract
Justification: The hypertension pervasiveness is a major challenge in human immunodeficiency virus (HIV) afflicted people globally. Aim: A prospective, cross-sectional research comprising two hundred and eighteen HIV afflicted patients was conducted in Antiretroviral Therapy Clinic of General Hospital, Offa, Nigeria between November 2015 and December 2016. Methodology: Blood pressure of patients was evaluated with the use of Omron automated blood pressure monitor following standard procedures. Dual Weight and Height Balance device was utilized to measure the weights and heights of the subjects. Results: Hypertension incidence among patients receiving combined antiretroviral therapy (cART) was 34%, while cART-naive was 9.6%. In women afflicted with HIV who were on cART, the hypertension occurrence was high (75.5%) compared to men (24.5%). Risk factors that were markedly linked with hypertension among patients on cART include body mass index (OR: 3.29, 95% CI: 1.21-2.27; p < 0.050), sedentary lifestyle (OR: 1.63, 95% CI: 1.20-5.38; p < 0.043), age (OR: 2.17, 95% CI: 1.22-2.33; p < 0.004) and gender (OR: 1.63, 95% CI: 0.85-2.41; p < 0.037). Conclusion: Patients on cART were found to have higher hypertension prevalence than cART-naive. On risk factors for hypertension, however, the cART was not inclusive.
Publication Details
Page(s) 4-10
DOI DOI not available
Published Journal: RADS Journal of Pharmacy & Pharmaceutical Sciences, Volume: 5, Issue: 4, Year: 2017

Request the full text from PASTIC

Keywords
gender, Blood pressure, Body Mass Index, women.
References
2017.Fact sheet - Latest statistics on the status of the AIDS epidemic,Retrieved on 7th June -
SsinabulyaI,KayimaJ,LongeneckerC,LuweddeM,SemitalaF,KambuguA,AmedaF,BugezaS,McComseyG,FreersJ,NakanjakoD., .Subclinical atherosclerosis among HIV-infected adults attending HIV/AIDS care at two large ambulatory HIV clinics in Uganda,2014 Feb 28 e89537 -
DimalaCA,AtashiliJ,MbuagbawJC,WilfredA,MonekossoGL, .Prevalence of hypertension in HIV/AIDS patients on highly active antiretroviral therapy (HAART) compared with HAART-naïve patients at the Limbe Regional Hospital, Cameroon,2016 Feb 10 e0148100 -
ArrudaJunior,ER , Lacerda,HR , Moura,LC , Albuquerque,MD , Miranda Filho,DD , Diniz,GT , Albuquerque,VM , Amaral,JC , Ximenes,RA , Monteiro,VS,J InfectDis, 2010.Risk factors related to hypertension among patients in a cohort living with HIV/AIDS, 14 281 -7
BloomfieldGS,KhazanieP,MorrisA,RabadánDiehlC,BenjaminLA,MurdochD,RadcliffVS,VelazquezEJ,HicksC, .HIV and noncommunicable cardiovascular and pulmonary diseases in low-and middle-income countries in the ART era: what we know and best directions for future research,2014 Sep 1 S40 -
2007.Class of antiretroviral drugs and the risk of myocardial infarction,N Engl J Med 356 1723 -35
BaekkenM,OsI,SandvikL,OektedalenO., 2008.Hypertension in an urban HIV-positive population compared with the general population: influence of combination antiretroviral therapy,J Hypertens 26 2126 -33
ShererR,SolomonS,SchechterM,NachegaJB,RockstrohJ,ZunigaJM, 2014.HIV Provider-Patient Communication Regarding Cardiovascular Risk: Results from the 2010 AIDS Treatment for Life International Survey,J Int Assoc Provid AIDS Care 13 342 -5
DubéMP,LipshultzSE,FichtenbaumCJ,GreenbergR,SchecterAD,FisherSD, 2008.Effects of HIV infection and antiretroviral therapy on the heart and vasculature,Circulation 118 e36 -40
AraoyeMO, 2003.Research methodology with statistics for health and social sciences,Ilorin: Nathadex Publisher 115 -
ChenY,ChenX,DangG,ZhaoY,OuyangF,SuZ,ZengJ, 2015.Hypertension criterion for stroke prevention-to strengthen the principle of individualization in guidelines,The J Clin Hyperten 17 232 -8
GanzML,WintfeldN,LiQ,AlasV,LangerJ,HammerM., 2014.The association of body mass index with the risk of type 2 diabetes: a case-control study nested in an electronic health records system in the United States,Diabetol. Metab Syndr 6 50 -
SAS,SASInstitute,NC, 2012.The Statistical Application Software (SAS) Statistics System for Windows Release Version 9.2, -
LichtensteinKA,ArmonC,BuchaczK,ChmielJS,BucknerK,Tedaldi EM,BrooksJT,HIV Outpatient, 2010.Low CD4+ T cell count is a risk factor for cardiovascular disease events in the HIV outpatient study,Clin Infect Dis 51 435 -47
YoneEW,BetyouminAF,KengneAP,FolefackFJ,NgogangJ, 2011.First-line antiretroviral therapy and dyslipidemia in people living with HIV-1 in Cameroon: a cross-sectional study,AIDS Res Ther 8 33 -
EkaliLG,JohnstoneLK,Echouffo-TcheuguiJB,KouanfackC,DehayemMY,FezeuL, 2013.Fasting blood glucose and insulin sensitivity are unaffected by HAART duration in Cameroonians receiving first-line antiretroviral treatment,Diabetes Metab 39 71 -7
NjelekelaM,MuhihiA,AveikaA,SpiegelmanD,HawkinsC,ArmstrongC, 2016.Prevalence of hypertension and its associated risk factors among 34,111 HAART naïve HIV-infected adults in Dar es Salaam, Tanzania,Int J Hypertens 5958382 -
AgrawalA,MitalP,GoyalLK,AgarwalA,NawalCL,KumarV, 2015.Research Article A Study of Risk Factors and Impact of HAART on Blood Pressure in North Indians Living With HIV/AIDS,Acad. J. Biosci 3 98 -103
KanegaeH,OikawaT,OkawaraY,HoshideS,KarioK., 2017.Which blood pressure measurement, systolic or diastolic, better predicts future hypertension in normotensive young adults? J Clin Hypertens, 19 603 -10
MutedeBR,MagureT,GombeNT,BangureD,TshimangaM,MungatiM. Prevalence, 2015.an analytic cross-sectional study,World J Cardiovasc 5 266 -
KaplanRC,KingsleyLA,SharrettAR,LiX,LazarJ,TienPC,MackWJ,CohenMH,JacobsonL,GangeSJ, 2007.Ten-year predicted coronary heart disease risk in HIV-infected men and women,Clin Infect Dis 45 1074 -81
DeeksSG,PhillipsAN, 2009.HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity,BMJ 338 a3172 -
KowalskaJD,ReekieJ,MocroftA,ReissP,LedergerberB,GatellJ,MonforteAD,PhillipsA,LundgrenJD,KirkO, 2012.EuroSIDA study group. Long-term exposure to combination antiretroviral therapy and risk of death from specific causes: no evidence for any previously unidentified increased risk due to antiretroviral therapy,Aids 26 315 -23
HarrisonDG,GuzikTJ,LobH.,Inflammation, 2011.,Hypertension 57 132 -40
2010.,Global Status Report on Non-Communicable Diseases -
0

Citations

0

Downloads

59

Views